Aurora Hashish Inc. (NYSE:ACB) Receives Common Advice of “Maintain” from Brokerages

Shares of Aurora Cannabis Inc. (NYSE:ACB – Get Rating) have been given a consensus recommendation of “Hold” by the eight research firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $5.18.

ACB has been the topic of several analyst reports. Cantor Fitzgerald upgraded Aurora Cannabis from a “neutral” rating to an “overweight” rating in a report on Friday, June 24th. CIBC reduced their price target on Aurora Cannabis from C$6.50 to C$3.75 in a report on Monday, May 16th. Finally, Stifel Nicolaus upgraded Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 price target on the stock in a report on Monday, June 6th.

Aurora Cannabis Trading Down 1.3%

Shares of ACB opened at $1.50 on Friday. Aurora Cannabis has a 52-week low of $1.21 and a 52-week high of $8.69. The company has a quick ratio of 4.76, a current ratio of 5.85 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $1.43 and its two-hundred day moving average is $2.83. The stock has a market cap of $340.20 million, a PE ratio of -0.32 and a beta of 2.74.

Aurora Cannabis (NYSE:ACB – Get Rating) last announced its earnings results on Thursday, May 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.88). Aurora Cannabis had a negative return on equity of 25.80% and a negative net margin of 542.50%. The business had revenue of $39.82 million for the quarter, compared to analyst estimates of $40.58 million. Research analysts forecast that Aurora Cannabis will post -1.65 earnings per share for the current fiscal year.

Institutional Trading of Aurora Cannabis

Institutional investors and hedge funds have recently bought and sold shares of the stock. Horan Securities Inc. acquired a new position in shares of Aurora Cannabis during the fourth quarter worth about $54,000. Gotham Asset Management LLC purchased a new stake in shares of Aurora Cannabis during the fourth quarter worth approximately $64,000. City State Bank purchased a new position in Aurora Cannabis in the fourth quarter worth $40,000. MQS Management LLC purchased a new position in Aurora Cannabis in the first quarter worth $49,000. Finally, HighTower Advisors LLC purchased a new position in Aurora Cannabis in the first quarter worth $50,000. 15.47% of the stock is currently owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

(Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Aurora Cannabis right now?

Before you consider Aurora Cannabis, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.

While Aurora Cannabis currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here